![](/-/media/marketing/podcast-hub/curve-soundwavesv2.png?h=127&w=450&rev=ed628250f17d432694713eb34826fe1a&hash=D756445CB26D3B6A1B5E442D7871B2D7)
Scrip Podcasts
Listen to Scrip podcasts for our perspectives on biopharma R&D, deal-making, product strategies and other key commercial topics.
![](/-/media/editorial/scrip/00_regular-column-images/sc2008_fivemustknowthings_1200_final.jpg?rev=e6ab2761c1e6477ebef4a5c11f824cfe&w=350&hash=85D113D905C9FDFC44BA47966C7DE910)
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: global CEO remuneration; another late-stage loss for Merch KgaA; deals shift to smaller M&A, partnering; Bayer’s Parkinson’s bets bear fruit; and India looks to innovate CAR-T models.
![](/-/media/editorial/scrip/00_regular-column-images/chinesebiotech_podcast_1200.jpg?rev=d3d2a7761a5b4b608755f8bc405705b6&w=350&hash=0937111524C56EFA47CE6E840881483D)
China Biotech Podcast: 数据出境新规解读,EHA和ADA的中国数据发布
In this Chinese-language podcast episode, "Angus" Shipo Xie, a lawyer at Han Kun Law, joins Brian Yang to discuss the implications of China's updated Data Overseas Transfer rules issued in late March. Dexter Yan explains clinical data released by Hutchmed, Jiangsu Hengrui and Innovent Bio at the recent EHA and ADA annual conferences.
![](/-/media/editorial/scrip/00_regular-column-images/sc2008_fivemustknowthings_1200_final.jpg?rev=e6ab2761c1e6477ebef4a5c11f824cfe&w=350&hash=85D113D905C9FDFC44BA47966C7DE910)
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: the outlook for 2025 launches; Merck confident in new pneumococcal vaccine; multiple US setbacks for Japanese firms; Stock Watch on Moderna missteps; and Sun’s North America head talks plans and strategy.
![](/-/media/editorial/scrip/2024/06/asco_2024/sc2406_asco_image3_1200.png?rev=28f716603be74b3cbf3cfc928adda29e&w=350&hash=ECEA63C2C5AA2C7BAC1C2F239F096923)
ASCO 2024 Wrap-Up Podcast
Scrip reporter Alaric DeArment is joined by the Datamonitor Healthcare oncology analysts to review key highlights from the recent American Society of Clinical Oncology annual meeting.
![](/-/media/editorial/scrip/00_regular-column-images/sc2008_fivemustknowthings_1200_final.jpg?rev=e6ab2761c1e6477ebef4a5c11f824cfe&w=350&hash=85D113D905C9FDFC44BA47966C7DE910)
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: Boehringer best in MASH?; biopharma funding on an upswing?; Moderna’s combo jab; clinical trial recover from pandemic; and Astellas’s US commercial head speaks.
![](/-/media/editorial/scrip/00_regular-column-images/chinesebiotech_podcast_1200.jpg?rev=d3d2a7761a5b4b608755f8bc405705b6&w=350&hash=0937111524C56EFA47CE6E840881483D)
China Biotech Podcast: BIOSECURE Act Updates ASCO Highlights
US-based Citeline writer Sarah Karlin-Smith joins Brian Yang and Dexter Yan in China to discuss the US BIOSECURE Act and the recent BIO meeting in San Diego, while Dexter Yan discusses China-related ASCO highlights, in this mixed Chinese- and English-language episode.
Podcast: Building And Scaling Your Workforce: The Importance Of A Flexible Delivery Model In 2024 & Beyond
In this podcast, Janelle Hart, Managing Editor, Citeline, joins together with industry experts, Jessica Wall, Director of Talent Acquisition, and Morgan Seaman, Associate Director of FSS Operations, both from Advanced Clinical, to discuss the latest trends and challenges in building, scaling and differentiating workforces in the life sciences sector.
![](/-/media/editorial/scrip/00_regular-column-images/sc2008_fivemustknowthings_1200_final.jpg?rev=e6ab2761c1e6477ebef4a5c11f824cfe&w=350&hash=85D113D905C9FDFC44BA47966C7DE910)
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: BIO Notebook; ASCO roundup; data on Carvykti in community at ASCO; strong new results for tirzepatide in MASH; and orphan slowdown signals new path ahead.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.